Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2004
12/14/2004US6830621 Liquid discharge apparatus for producing probe carrier, apparatus for producing probe carrier and method for producing probe carrier
12/14/2004CA2296535C Antisense oligonucleotide inhibition of ras
12/14/2004CA2290740C Method based on the use of bacteriophages for the detection of biological molecules in biological samples
12/14/2004CA2180555C Radiolabeled annexins
12/14/2004CA2169355C Tumor suppressor protein prb2, related gene products, and dna encoding therefor
12/14/2004CA2146320C Antisense oligonucleotide inhibition of the ras gene
12/14/2004CA2104957C Redirection of cellular immunity by receptor chimeras
12/14/2004CA2091444C Media for culture of insect cells
12/14/2004CA1341468C Preparation of functional human factor viii
12/09/2004WO2004107244A1 Information processing method using nucleic acid molecules
12/09/2004WO2004107243A1 Method for designing dna codes used as information carrier
12/09/2004WO2004106932A1 Method for selecting allosteric regulators of class iii g protein-coupled receptors
12/09/2004WO2004106557A2 Thiamin production by fermentation
12/09/2004WO2004106550A2 Identification and/or analysis of nucleic acids and/or proteins associated with a chromosome location
12/09/2004WO2004106543A1 An improved genetic screen for interaction interface mapping
12/09/2004WO2004106541A1 Periodontal disease marker
12/09/2004WO2004106532A1 Modified polypeptides for targeting cell-entry of the adenoviruses of subtype b
12/09/2004WO2004106531A1 Method for manipulating growth, yield, and architecture in plants
12/09/2004WO2004106530A1 Novel promoters
12/09/2004WO2004106529A2 Wheat plants having increased tolerance to imidazolinone herbicides
12/09/2004WO2004106528A1 Transgenic monocotyledonous plants overexpressing a nhx protein and having improved growth charcteristics and a method for making the same
12/09/2004WO2004106527A1 Archaeon expression system
12/09/2004WO2004106526A1 Vector for cloning an insert having blunt ends, enabling recombinant clones to be positively selected, method for cloning in said vector, and use of said vector for expressing an insert
12/09/2004WO2004106525A1 A fusion protein suitable to be expressed high effectively and the production method thereof
12/09/2004WO2004106524A1 Protease, dna coding for the protease and process for producing the protease
12/09/2004WO2004106523A1 Compositions and methods for preventing and treating liver cirrhosis
12/09/2004WO2004106522A1 Gene encoding a ribosome-inactivating protein, known as recombinant musarmin 4, expression in bacterial system, method of obtaining same and applications thereof
12/09/2004WO2004106521A1 Canine cyp1a2 gene polymorphism
12/09/2004WO2004106520A1 Plant gene activation vector and utilization thereof
12/09/2004WO2004106519A2 Mrp8/mrp14 inhibitors and the use thereof for preventing and/or treating hypertrophic scars and keloids
12/09/2004WO2004106518A1 Antisense oligonucleotides directed to ribonucleotide reductase r2 and uses thereof in the treatment of cancer
12/09/2004WO2004106517A1 Double-stranded nucleic acid
12/09/2004WO2004106516A1 Method for obtaining plasmid-dna by means of an aqueous biphasic system
12/09/2004WO2004106514A1 Method of recovering protein by deubiquitinating ubiquitinated protein
12/09/2004WO2004106513A1 Host cells deficient for mismatch repair
12/09/2004WO2004106512A1 Method of enhancing pathogen-resistance of plant
12/09/2004WO2004106511A1 OLIGO DOUBLE-STRANDED RNA INHIBITING THE EXPRESSION OF Bcl-2 AND MEDICINAL COMPOSITION CONTAINING THE SAME
12/09/2004WO2004106510A1 Enzyme with xylanase activity at acidic ph
12/09/2004WO2004106508A2 Bioreactor containing cells expressing glycosyltransferase nucleic acids
12/09/2004WO2004106505A1 A gutless adenovirus vector and the construction method thereof
12/09/2004WO2004106504A1 The recombinant adeno-associated viruses carrying the human gamma interferon and the metrod for preparing them
12/09/2004WO2004106503A1 Novel il-8-like polypeptides
12/09/2004WO2004106496A2 Methods and compositions for use in homologous recombination in plant cells
12/09/2004WO2004106488A2 Gene expression suppression agents
12/09/2004WO2004106411A2 Biodegradable poly(beta-amino esters) and uses thereof
12/09/2004WO2004106369A2 Complement inhibitors from ticks
12/09/2004WO2004106368A1 Generation of artificial binding proteins based on ubiquitin proteins
12/09/2004WO2004106367A2 Enterococcus antigens
12/09/2004WO2004106360A2 Viral vectors with improved properties
12/09/2004WO2004105774A1 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite
12/09/2004WO2004105737A2 Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
12/09/2004WO2004105681A2 Cd4+ human papillomavirus (hpv) epitopes
12/09/2004WO2004105503A1 Method of improving taste and/or flavor of food or drink
12/09/2004WO2004105477A2 Method for cloning in the rat by nuclear transfer
12/09/2004WO2004105466A2 Floral transformation
12/09/2004WO2004096288A3 Method of obtaining dna replication minicircles which are intended to be used for gene transfer or as immunomodulators
12/09/2004WO2004093919A3 Target for cancer therapy and drug discovery
12/09/2004WO2004089422A3 Methods of treating and monitoring systemic lupus erythematosus in individuals
12/09/2004WO2004087966A3 Genomic profiling of regulatory factor binding sites
12/09/2004WO2004085660A3 Improved alphavirus replicons and helper constructs
12/09/2004WO2004085659A3 Mutant vesicular stomatitis viruses and uses thereof
12/09/2004WO2004083436A9 Novel bt toxin receptors and methods of use
12/09/2004WO2004081170A3 Progestin receptor-like protein
12/09/2004WO2004077010A3 Water channel assays
12/09/2004WO2004076615A3 Immunomodulating probiotic compounds
12/09/2004WO2004069996A3 Bacteria and process for producing chemical compounds by said bacteria
12/09/2004WO2004067725A3 Methods of identifying modulators of nmur2-mediated activity
12/09/2004WO2004062618A3 Method for in vivo regulation of cardiac muscle contractility
12/09/2004WO2004050692A3 Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production
12/09/2004WO2004047742A3 Multivalent aptamer therapeutics with improved pharmacodynamic properties and methods of making and using the same
12/09/2004WO2004047736A3 Modulation of bcl2-associated athanogene expression
12/09/2004WO2004044151A3 Recombinase mediated transcription
12/09/2004WO2004043344A3 Anti-cd33 antibodies and method for treatment of acute myeloid leukemia using the same
12/09/2004WO2004042074A3 Methods for the identification of agents that modulate the structure and processing of a membrane bound precursor protein
12/09/2004WO2004038003A3 Human polypeptides encoded by polynucleotides and methods of their use
12/09/2004WO2004037983A3 Caged ligands and uses thereof
12/09/2004WO2004026238A3 Immunotherapeutic compositions and methods for the treatment of moderately to well-differentiated cancers
12/09/2004WO2004018693A3 Method for the production of ketocarotinoids in flower petals on plants
12/09/2004WO2004017728A3 Methods
12/09/2004WO2004017042A3 Methods and reagents for surface functionalization
12/09/2004WO2004011624A3 Double stranded rna structures and constructs, and methods for generating and using the same
12/09/2004WO2004006866A3 Antifungal therapeutic targets
12/09/2004WO2004003148A3 Genes encoding proteins with pesticidal activity
12/09/2004WO2003104258A3 Dominant gene delaying flowering
12/09/2004WO2003103377A3 Methods and compositions for production of maize lines with increased transformability
12/09/2004WO2003102588A3 Diagnostic agent, method for detecting a carcinoma, and means for the treatment thereof
12/09/2004WO2003100070A3 The frog prince, a transposon vector for gene transfer in vertebrates
12/09/2004WO2003097790A3 Genes and uses thereof to modulate secondary metabolite biosynthesis
12/09/2004WO2003093478A9 Immunoconjugates for the treatment of tumours
12/09/2004WO2003087301A3 Methods and compositions for dna manipulation
12/09/2004WO2003080808A3 Novel compositions and methods in cancer
12/09/2004WO2003074726A3 Immune response associated proteins
12/09/2004WO2003072114A9 Vascular therapeutics
12/09/2004WO2003062382A3 Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals
12/09/2004WO2003062262A3 Modulation of heat-shock-protein-based immunotherapies
12/09/2004WO2003057835A3 Pak5-related compositions and methods
12/09/2004WO2003014142A3 Phosphorylated histone h2b as an apoptosis marker
12/09/2004WO2002090300A3 Nucleic acids and proteins with thioredoxin reductase activity
12/09/2004WO2002044381A8 Human vno receptor (r1)
12/09/2004US20040250317 Cotton event moni5985 and compositions and methods for detection thereof